Longdom Conferences

Speaker

July 22, 2020    London, UK

Webinar on Microbiology and Future Applications

farihaaltaaf
Room1

farihaaltaaf

Pakistan

Title: Seroprevalence of Bluetongue virus originating among camels from southern Punjab, Pakistan

Abstract:

Bluetongue (BT), caused by bluetongue virus (BTV) is a vector-borne disease of small ruminants such as sheep, goat and also persist in camels. Bluetongue (BT) disease has a prospective to spread across borders. In spite of large number of populations of susceptible animals and borders with BTV endemic countries, scant is known of disease implication and prevalent serotype in southern Punjab province in Pakistan. We escort a cross-sectional study to determine seroprevalence of bluetongue virus in selected districts of southern Punjab using a competitive enzyme-linked immunosorbant assay (cELISA). Sera (n = 992) were collected from clinically healthy and non-healthy camels originating from the districts of Bahawalpur (n = 30), Dera Ghazi Khan (n = 207), Multan (n = 100), Muzaffargarh (n = 17), Rahim Yar Khan (n = 255), Rajanpur (n = 152), Taunsa (n = 231). At the individual level, the overall prevalence of BTV was 68% (n = 697/992, 95% CI = 33.11- 38.72%). A higher percentage of seroprevalence was seen in district Muzaffargarh 100% (n = 17/17). Odd ratios of seroprevalence for camels were associated with age type (ᵡ² = 139.59, p = .00), body condition (ᵡ² = 40.61, p = .00), breed (ᵡ² = 19.61, p = .00), feeding status (ᵡ² = 7.96, p = 0.19), farming status (ᵡ² = 24.49, p = .00), Education status (ᵡ² = 11.68, p = .00), pregnancy status (ᵡ² = 21.80, p .00). All the risk factors were significant and contribute towards the presence of BT disease. To the best of our knowledge, this study that has been conducted in southern Punjab province and the results of this study designate to instigate intrusion strategies to control the BT disease burden but not only in the area of Pakistan but also in in neighboring countries to whom Pakistan share

Biography:

I am Fariha Altaaf young research in the field of Microbiology belong to Pakistan. I have a passion and learn new expertise in evaluation in improving the health and wellbeing. I am very passionate and hardworking to create new pathways for improving healthcare. I have done this research and built this model after years of experience in microbiology research, evaluation, teaching and administration both from hospital and education institutions. The methodology in this research includes competitive ELISA that illustrates, seroprevalence and association of risk factors. It allows for value-pluralism. This research along this methodology reveals the presence of BT virus that is transmitted from one region to another and still transmitting. I also done a research in bacteriology section that was a project work on Streptococcus pneumoniae from Lahore University of Management Sciences (LUMS). I am very hardworking and keen towards my fieldwork. In my future I would like to be work as Microbiologist definitely.

Useful Links

News

Coronavirus disease (COVID-19)

2020-03-12

Coronaviruses (CoV) are a large family of viruses that cause illness ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV). A novel coronavirus (nCoV) is a new strain that has not been previously identified in humans. Coronaviruses are zoonotic, meaning they are transmitted between animals and people. Detailed investigations found that SARS-CoV was transmitted from civet cats to humans and MERS-CoV from dromedary camels to humans. Several known coronaviruses are circulating in animals that have not yet infected humans. Common signs of infection include respiratory symptoms, fever, cough, shortness of breath and breathing difficulties. In more severe cases, infection can cause pneumonia, severe acute respiratory syndrome, kidney failure and even death. Standard recommendations to prevent infection spread include regular hand washing, covering mouth and nose when coughing and sneezing, thoroughly cooking meat and eggs. Avoid close contact with anyone showing symptoms of respiratory illness such as coughing and sneezing.

World experts and funders set priorities for COVID-19 research

2020-03-12

Leading health experts from around the world have been meeting at the World Health Organization’s Geneva headquarters to assess the current level of knowledge about the new COVID-19 disease, identify gaps and work together to accelerate and fund priority research needed to help stop this outbreak and prepare for any future outbreaks. The 2-day forum was convened in line with the WHO R&D Blueprint – a strategy for developing drugs and vaccines before epidemics, and accelerating research and development while they are occurring. “This outbreak is a test of solidarity -- political, financial and scientific. We need to come together to fight a common enemy that does not respect borders, ensure that we have the resources necessary to bring this outbreak to an end and bring our best science to the forefront to find shared answers to shared problems. Research is an integral part of the outbreak response,” said WHO Director-General Dr Tedros Adhanom Ghebreyesus. “I appreciate the positive response of the research community to join us at short notice and come up with concrete plans and commitment to work together.” The meeting, hosted in collaboration with GloPID-R (the Global Research Collaboration for Infectious Disease Preparedness) brought together major research funders and over 300 scientists and researchers from a large variety of disciplines. They discussed all aspects of the outbreak and ways to control it including: the natural history of the virus, its transmission and diagnosis; animal and environmental research on the origin of the virus, including management measures at the human-animal interface; epidemiological studies; clinical characterization and management of disease caused by the virus; infection prevention and control, including best ways to protect health care workers; research and development for candidate therapeutics and vaccines; ethical considerations for research; and integration of social sciences into the outbreak response.

Newsletter

© 2024 All Rights Reserved by Longdom